Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications
Rui Bernardino(University Health Network), Susan Prendeville(University of Toronto), Neil Fleshner(Princess Margaret Cancer Centre), Ugo Giovanni Falagario(Ospedali Riuniti di Foggia), Vittorio Fasulo(Humanitas University), Lara Rodríguez‐Sánchez(Institute Mutualiste Montsouris), August Sigle(University Medical Center Freiburg), Akihiro Matsukawa(Okayama University), Matthijs J. Scheltema(Garvan Institute of Medical Research), Jennifer Le Guévelou(Centre Eugène Marquis), Tamás Fazekas(Semmelweis University), Alberto Martini(The University of Texas MD Anderson Cancer Center), Felix Preißer(Royal Free London NHS Foundation Trust), Matteo Bauckneht(Azienda Ospedaliera S.Maria), Ignacio Puche‐Sanz(Instituto de Investigación Biosanitaria de Granada), Veeru Kasivisvanathan(University College London Hospitals NHS Foundation Trust), Rossella Nicoletti(University Medical Center Utrecht), Francesca Ambrosini(Ospedale Policlinico San Martino), Martina Maggi(Policlinico Umberto I), Marie C. Roesch(Jikei University School of Medicine), Theodorus van der Kwast(Erasmus MC), Marcin Miszczyk(Comprehensive Cancer Center Vienna), Alexander Giesen(Vita-Salute San Raffaele University), Jihad Kaouk(Cleveland Clinic), Claudia Kesch(Essen University Hospital), Isabel Heidegger(Innsbruck Medical University), Jonathan Olivier(Université de Lille), Hein Vincent Stroomberg, Timo Soeterik(St. Antonius Ziekenhuis), Fabio Zattoni, Lorenzo Bianchi(Azienda USL di Bologna), Chiara Mercinelli, João Lobo(Universidade do Porto), Francesco Giganti(University College London Hospitals NHS Foundation Trust), Paweł Rajwa(University College London), Renee Hogehout(Erasmus MC)
Cited by 0
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705